NO992902L - Diagnostiske markoerer for humane sykdommer - Google Patents
Diagnostiske markoerer for humane sykdommerInfo
- Publication number
- NO992902L NO992902L NO992902A NO992902A NO992902L NO 992902 L NO992902 L NO 992902L NO 992902 A NO992902 A NO 992902A NO 992902 A NO992902 A NO 992902A NO 992902 L NO992902 L NO 992902L
- Authority
- NO
- Norway
- Prior art keywords
- diseases
- diagnostic markers
- peptides
- human diseases
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9486—Analgesics, e.g. opiates, aspirine
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Botany (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8923798P | 1998-06-15 | 1998-06-15 | |
US8923898P | 1998-06-15 | 1998-06-15 | |
US31770299A | 1999-05-24 | 1999-05-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO992902D0 NO992902D0 (no) | 1999-06-14 |
NO992902L true NO992902L (no) | 1999-12-16 |
Family
ID=27376259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO992902A NO992902L (no) | 1998-06-15 | 1999-06-14 | Diagnostiske markoerer for humane sykdommer |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0969015A3 (ko) |
JP (1) | JP2000221191A (ko) |
KR (1) | KR20000006190A (ko) |
CN (1) | CN1247984A (ko) |
CA (1) | CA2273683A1 (ko) |
NO (1) | NO992902L (ko) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO318426B1 (no) * | 2001-10-02 | 2005-04-18 | Neurozym Biotech As | Et materiale for a senke konsentrasjonen av patogene tarmpeptider |
SE0300586L (sv) | 2003-03-04 | 2004-09-05 | Forskarpatent I Syd Ab | Diagnos av autism |
GB0504096D0 (en) * | 2005-02-28 | 2005-04-06 | Tipogen As | Method |
US9547013B2 (en) * | 2010-04-29 | 2017-01-17 | Wisconsin Alumni Research Foundation | Molecule biomarkers of autism |
JPWO2013047082A1 (ja) * | 2011-09-29 | 2015-03-26 | 天野エンザイム株式会社 | 外因性オピオイドペプチド分解酵素剤 |
KR102191787B1 (ko) * | 2015-10-14 | 2020-12-17 | 삼육대학교산학협력단 | Adhd 검출용 바이오마커 |
RU2651038C1 (ru) * | 2017-07-21 | 2018-04-18 | Федеральное бюджетное учреждение науки "Федеральный научный центр медико-профилактических технологий управления рисками здоровью населения" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН "ФНЦ медико-профилактических технологий управления рисками здоровью | Способ выявления нарушений у детей иммунологической реактивности в условиях избыточной экспозиции стронцием |
US11491144B2 (en) | 2018-03-30 | 2022-11-08 | The Florida State University Research Foundation, Incorporated | Methods of treating fragile X mental retardation syndrome |
KR102341323B1 (ko) | 2020-07-07 | 2021-12-21 | 한국원자력의학원 | 미세플라스틱 노출에 의해 유도되는 뇌질환 예후 예측용 바이오마커 조성물 및 이를 이용한 예후 예측방법 |
KR102639856B1 (ko) | 2020-10-14 | 2024-02-23 | 한국원자력의학원 | 미세플라스틱 노출에 의해 유도되는 뇌질환 예후 예측용 바이오마커 조성물 및 이를 이용한 예후 예측방법 |
-
1999
- 1999-06-08 CA CA002273683A patent/CA2273683A1/en not_active Abandoned
- 1999-06-14 NO NO992902A patent/NO992902L/no not_active Application Discontinuation
- 1999-06-15 EP EP99304636A patent/EP0969015A3/en not_active Withdrawn
- 1999-06-15 JP JP11168555A patent/JP2000221191A/ja active Pending
- 1999-06-15 KR KR1019990022247A patent/KR20000006190A/ko not_active Application Discontinuation
- 1999-06-15 CN CN99108478A patent/CN1247984A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2273683A1 (en) | 1999-12-15 |
EP0969015A3 (en) | 2002-10-09 |
JP2000221191A (ja) | 2000-08-11 |
NO992902D0 (no) | 1999-06-14 |
EP0969015A2 (en) | 2000-01-05 |
KR20000006190A (ko) | 2000-01-25 |
CN1247984A (zh) | 2000-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999040197A3 (en) | Variants of the angiogenic factor vascular endothelial cell growth factor: vegf | |
AU3368497A (en) | Human dnase i hyperactive variants | |
CA2274596A1 (en) | Compositions and methods for enhancing intestinal function | |
GR3031488T3 (en) | Laminin chains: diagnostic and therapeutic use | |
HRP20010877B1 (en) | Composition for prevention and treatment of amyloidogenic disease | |
NO992902L (no) | Diagnostiske markoerer for humane sykdommer | |
DE69427650D1 (de) | Verbindungen mit wachstumshormon-freisetzenden eigenschaften | |
TW200640944A (en) | VGF polypeptides and methods of treating VGF-related disorders | |
HUP0102479A2 (hu) | Neisseria meningitidis-ből származó BASBO29-polinukleotid(ok) és polipeptidek | |
HK1025793A1 (en) | Hepatitis c receptor protein cd81 | |
NO963487L (no) | Isolerte, tyrosinaseavledete peptider, samt anvendelser derav | |
MXPA02000680A (es) | Polipeptidos vgf y metodos para tratar desordenes relacionados con vgf. | |
CY1105116T1 (el) | Χρηση των il-6r/il-6 χιμαιρων στη νοσο του huntington | |
HK1061209A1 (en) | Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 | |
NO995692D0 (no) | Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse | |
ATE230263T1 (de) | At1 rezeptor antagonist zur anregung von apoptosis | |
WO1999055859A3 (en) | Cd40-interacting and traf-interacting proteins | |
WO2002070563A3 (en) | Nuclear hormone receptor ligand binding domain | |
DK0811068T3 (da) | Humane DNase I varianter | |
GB0426960D0 (en) | TGR-3 like protein receptor | |
Ross | New life for old medicine. | |
WO2004005346A8 (en) | Human nuclear hormone receptor | |
WO2003106666A3 (en) | VARIANTS OF PROTEIN C WITH MODIFIED PROPERTIES | |
WO2001000655A3 (en) | Therapeutic peptides derived from subsequences of bpi | |
GB0216727D0 (en) | Genes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |